Difosfocin

Active substance

Citicoline

Strenght and pharmaceutical forms

500 mg/4 ml injectable solution – 5 ampoules
1000 mg/4 ml injectable solution – 3 ampoules

ATC

N06BX06 - Psychostimulants and nootropes

Therapeutic Indications

arkinson’s syndrome support treatment.

Marketing Authorization Holder

Magis Farmaceutici S.r.l.

Download area

Summary of Product Characteristics - Difosfocin

Review from Journal of Medicine and Medical Science Research